Table 1 Main clinical items collected in the BACAP cohort
From: A prospective clinical and biological database for pancreatic adenocarcinoma: the BACAP cohort
Type | Data collected |
|---|---|
Socio-demographic | Age, gender, medical history and medication use, work and educational level, alcohol and tobacco consumption, BMI, family history of cancer |
Symptoms | First symptoms of the disease, period between first symptoms and first consultation, venous or arterial thrombosis, metastasis (lymph nodes, ascites), performance status with WHO score |
Biology | Standard including liver enzymes, lipids, coagulation, CA 19–9 |
Diagnosis | Radiology, EUS, MRI and PET-scan, pre-therapeutic staging (CT-scan and EUS), cytopathology, |
Pathology | Fine needle biopsy or resected specimen: differentiation, lymph nodes, metastases, R status and TNM staging |
Treatment(s) | Chemotherapy (first, second and possibly third line), surgery, neo-adjuvant treatment, adjuvant treatment, best supportive care |
Follow-up | For each visit, the following were collected: standard laboratory tests, CT scan evaluation, chemotherapy treatment, treatment toxicities, and supportive care. The follow-up ended on the date of death. |